Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study
Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study
Zijun Zhu, Chaoyong Zhu, Dengfeng Ren, Jiuda Zhao et al.
Citations
11 citations
Journal
EClinicalMedicine
Topics
Pharmacovigilance and Adverse Drug Reactions
Field-Weighted Citation Impact (FWCI)
14.38
article
Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study